EPISODE · Feb 12, 2025 · 6 MIN
Trials in EGFR Mutated NSCLC: Mariposa2 and Laura- 2024 Leading Developments in Lung Cancer
from GRACEcast - Discussions with the Global Resource for Advancing Cancer Education · host cancerGRACE
Drs. Desai and Abu Rous discuss trial date from Mariposa2 and Laura as presented at 2024 ASCO, and the implications in treating EGFR+ NSCLC.
Embed this episode
NOW PLAYING
Trials in EGFR Mutated NSCLC: Mariposa2 and Laura- 2024 Leading Developments in Lung Cancer
0:00
6:26
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GRACEcast - Discussions with the Global Resource for Advancing Cancer Education?
This episode is 6 minutes long.
When was this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode published?
This episode was published on February 12, 2025.
Can I download this GRACEcast - Discussions with the Global Resource for Advancing Cancer Education episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!